| scholarly article | Q13442814 |
| P50 | author | Nosratollah Zarghami | Q47217602 |
| Hassan Dariushnejad | Q88184357 | ||
| P2093 | author name string | Mohammad Rahmati | |
| Hossein Jafari Tekab | |||
| Masoud Gandomkar Ghalhar | |||
| Samaneh Ghasemali | |||
| Zahra Davoodi | |||
| Zohreh Sadeghi | |||
| P2860 | cites work | Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy | Q39741953 |
| Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequences. | Q39950561 | ||
| The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin | Q40041107 | ||
| Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737. | Q40174205 | ||
| Synergistic effects of troglitazone in combination with cytotoxic agents in acute myelogenous leukaemia cells | Q40279213 | ||
| Bax-independent inhibition of apoptosis by Bcl-XL. | Q41229247 | ||
| The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. | Q42064781 | ||
| ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin-DNA adducts | Q43279608 | ||
| Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation | Q44926251 | ||
| Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer | Q46961763 | ||
| Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy | Q24635408 | ||
| Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors | Q29547463 | ||
| An inhibitor of Bcl-2 family proteins induces regression of solid tumours | Q29547595 | ||
| 'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737. | Q33266778 | ||
| Acute myeloid leukemia | Q33741270 | ||
| Role of the BH3 (Bcl-2 homology 3) domain in the regulation of apoptosis and Bcl-2-related proteins | Q33921266 | ||
| Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks | Q35743146 | ||
| The anthracycline antibiotics: antitumor drugs that alter chromatin structure | Q35990443 | ||
| Programmed cell death via mitochondria: different modes of dying. | Q36088226 | ||
| Drug therapy for acute myeloid leukemia | Q36115808 | ||
| Unique biology of Mcl-1: therapeutic opportunities in cancer | Q37108463 | ||
| Current and emerging therapies for acute myeloid leukemia | Q37683191 | ||
| The role of cytokines in acute myeloid leukemia: a systematic review. | Q38065929 | ||
| Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells | Q39360253 | ||
| Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737. | Q39427575 | ||
| P433 | issue | 2 | |
| P921 | main subject | acute myeloid leukemia | Q264118 |
| P304 | page(s) | 185-189 | |
| P577 | publication date | 2013-12-24 | |
| P1433 | published in | Advanced Pharmaceutical Bulletin | Q26853868 |
| P1476 | title | ABT-737, Synergistically Enhances Daunorubicin-Mediated Apoptosis in Acute Myeloid Leukemia Cell Lines | |
| P478 | volume | 4 |
Search more.